---
phase: 03-evidence-integration
plan: 03
subsystem: evidence
tags: [clinicaltrials-v2, uniprot-rest, chembl-client, tenacity, retry, protein-biology, bioactivity]

# Dependency graph
requires:
  - phase: 03-evidence-integration
    plan: 01
    provides: "EvidenceSource Protocol, EvidenceResult/GeneIdentifiers models, tenacity dependency"
provides:
  - "ClinicalTrialsSource: v2 REST API with condition + drug name filtering and pagination"
  - "UniProtSource: new REST API with protein function, domains, subcellular location"
  - "ChEMBLSource: Python client with UniProt accession -> target resolution -> bioactivities"
affects: [03-04, 05-scoring]

# Tech tracking
tech-stack:
  added: []
  patterns: [uniprot-accession-to-chembl-target-resolution, clinicaltrials-v2-pagination, drug-name-intervention-filtering]

key-files:
  created:
    - src/evidence/sources/clinicaltrials.py
    - src/evidence/sources/uniprot.py
    - src/evidence/sources/chembl.py
  modified: []

key-decisions:
  - "ClinicalTrials drug_names kwarg enables two-phase fetch: DGIdb runs first, drug names passed to ClinicalTrials via aggregator (REQ-204)"
  - "ChEMBL requires UniProt accession (not gene symbol) for target lookup -- returns confidence=0.0 if no accession available"
  - "UniProt queries use field selection (9 fields) to minimize response payload and parsing overhead"
  - "ClinicalTrials filters by overallStatus: RECRUITING,ACTIVE_NOT_RECRUITING,NOT_YET_RECRUITING for clinical relevance"

patterns-established:
  - "Two-phase fetch pattern: ClinicalTrials accepts drug_names kwarg populated by aggregator after DGIdb completes"
  - "Accession-based resolution: ChEMBL uses gene.uniprot_accession for target lookup (gene symbols not supported)"
  - "Graceful degradation: all three sources catch all exceptions and return EvidenceResult(confidence=0.0, error=str)"

# Metrics
duration: 4min
completed: 2026-05-10
---

# Phase 3 Plan 3: Additional Evidence Sources Summary

**ClinicalTrials.gov v2 REST source with drug name filtering, UniProt new REST API with protein biology extraction, ChEMBL Python client with UniProt accession-based target resolution**

## Performance

- **Duration:** 4 min
- **Started:** 2026-05-10T16:00:54Z
- **Completed:** 2026-05-10T16:04:47Z
- **Tasks:** 3
- **Files modified:** 3

## Accomplishments
- ClinicalTrialsSource querying v2 API with condition + drug intervention filtering, pagination via nextPageToken, and confidence scoring
- UniProtSource fetching protein function, subcellular location, domains, structure availability, and gene names via new REST API with field selection
- ChEMBLSource resolving UniProt accession to ChEMBL target ID, then fetching top 50 bioactivities (with pChEMBL statistics) and mechanisms of action

## Task Commits

Each task was committed atomically:

1. **Task 1: ClinicalTrials.gov v2 REST evidence source** - `2cfa2e2` (feat)
2. **Task 2: UniProt REST evidence source** - `167f048` (feat)
3. **Task 3: ChEMBL evidence source via Python client** - `4a9cbd9` (feat)

## Files Created/Modified
- `src/evidence/sources/clinicaltrials.py` - ClinicalTrials.gov v2 REST source with drug name filtering and pagination
- `src/evidence/sources/uniprot.py` - UniProt new REST API source with protein biology extraction
- `src/evidence/sources/chembl.py` - ChEMBL Python client source with accession-based target resolution

## Decisions Made
- ClinicalTrials drug_names kwarg enables aggregator's two-phase fetch pattern: DGIdb completes first, drug names forwarded to ClinicalTrials for relevant trial filtering (REQ-204)
- ChEMBL requires UniProt accession for target lookup (gene symbols not directly supported) -- returns confidence=0.0 gracefully if no accession available
- UniProt uses field selection (9 specific fields) to minimize response size and parsing complexity
- ClinicalTrials filters to active/recruiting trials only for clinical relevance to target assessment

## Deviations from Plan

None - plan executed exactly as written.

## Issues Encountered
None.

## User Setup Required
None - no external service configuration required. All APIs are public and require no authentication.

## Next Phase Readiness
- All six evidence sources now implemented (OpenTargets, DGIdb, PubMed from plan 03-02 + ClinicalTrials, UniProt, ChEMBL from this plan)
- Plan 03-04 can build the aggregator that orchestrates all sources, implements two-phase fetch for ClinicalTrials, and uses the evidence cache
- All 41 existing tests continue to pass (no regressions)

## Self-Check: PASSED

All 3 created files verified on disk. All 3 task commits (2cfa2e2, 167f048, 4a9cbd9) verified in git log.

---
*Phase: 03-evidence-integration*
*Completed: 2026-05-10*
